May 31st 2007: Dr. Avtar Dhillon MD, President and CEO, Inovio Biomedical Corp.
Dr. Dhillon will speak about Inovio's focus on the development of DNA-based immunotherapies for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers.